Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
116 participants
INTERVENTIONAL
2014-01-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Exergames on Muscle and Lung Function in Elderly
NCT06921057
Effects of Exergame in Patients at High Cardiovascular Risk.
NCT04042896
Development of an Exergame to Deliver a Sustained Dose of High-Intensity Training
NCT03477773
Interactive Exergaming With Otago Exercise Program on Mobility in Community-Dwelling Older Adults
NCT06814678
Exergaming for Community-Dwelling Older Adults
NCT04284709
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
H1: Compared with the control group participants (who do not use exergame) the experimental group participants (who use exergame) have better change in physical fitness. The difference between these two groups in the amount of change is negatively related to past exercise.
H2: Compared with the control group participants (who do not use exergame) the experimental group participants (who use exergame) have better change in (a) mental health and (b) physical health after the intervention. The difference between these two groups in the amount of change is negatively related to past exercise.
H3: Compared with the control group participants (who do not use exergame) the experimental group participants (who use exergame) have better change in (a) attitude, (b) intention and (c) behavior of doing another exercise in the future. The difference between these two groups in the amount of change is negatively related to past exercise.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
exergame
Participants were asked to use exergame (Xbox 360) half hour for three times per week in the 12-week study period.
Xbox 360
For each participant in the experimental arm, two Xbox 360 exercise items were randomly selected from the nine items, which are related to user health. Each participant takes the two exercise items in turn.
control
Participants were not asked to use exergames.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Xbox 360
For each participant in the experimental arm, two Xbox 360 exercise items were randomly selected from the nine items, which are related to user health. Each participant takes the two exercise items in turn.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* senior graduate student
Exclusion Criteria
* high myopia
* anemia
* vertigo
* cardiopathy
* hypertension
* unstable of intracranial pressure and blood pressure
* cardiac arrhythmia
* heart failure
* angor pectoris
* injury of vertebra
* ankylosing spondylitis
* hereditary cardiac arrhythmia
* musculoskeletal system injury
* glaucoma
* psychiatric disorders
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chang Gung Memorial Hospital
OTHER
Chang Gung University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ching-I Teng
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ching-I Teng, PhD
Role: PRINCIPAL_INVESTIGATOR
Chang Gung University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chang Gung University
Taoyuan District, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMRPD3D0021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.